A randomized multicenter study: safety and efficacy of mini-pool intravenous immunoglobulin versus standard immunoglobulin in children aged 1-18 years with immune thrombocytopenia-Reference-Cited by-同舟云学术

A randomized multicenter study: safety and efficacy of mini-pool intravenous immunoglobulin versus standard immunoglobulin in children aged 1-18 years with immune thrombocytopenia

Published:2017-09-06 Issue:12 Volume:57 Page:3019-3025
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Elalfy Mohsen¹,Reda Marwa¹,Elghamry Islam¹,Elalfy Omar²,Meabed Mohamed³,El-Ekiaby Nada⁴,El-Hawy Mahmoud A.⁵,Goubran Hadi⁶,El-Ekiaby Magdy⁷

Affiliation:

1. Department of Pediatric Hematology; Ain Shams University Hospitals, National Research Center; Cairo Egypt

2. Complementary Medicine Department; National Research Center; Cairo Egypt

3. Department of Pediatrics; Beni-Suef University; Beni-Suef Egypt

4. School of Medicine; Health Sciences Research Department, New Giza University; Giza Egypt

5. Department of Pediatrics; Menoufia University; Menoufia Egypt

6. University of Saskatchewan; Saskatoon Saskatchewan Canada

7. Hematology Unit, Blood Transfusion Center, Shabrawishi Hospital; Giza Egypt

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.14301/fullpdf

Reference24 articles.

1. Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in Europe;Kerr;Front Immunol,2014

2. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy;Jolles;Clin Immunol,2011

3. IVIG in autoimmune disease-potential next generation biologics;Zuercher;Autoimmun Rev,2016

4. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group;Rodeghiero;Blood,2009

5. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura;El Alfy;Acta Haematol,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards personalized and rational use of immunoglobulins amid expanding indications and shortages;Transfusion and Apheresis Science;2024-10

2. Response to comments from the International Patient Organization for Primary Immunodeficiencies on ‘Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries’;Vox Sanguinis;2024-06-18

3. Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries;Vox Sanguinis;2023-10-23

4. Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2;Transfusion Medicine Reviews;2022-07

5. Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome;Neurotherapeutics;2022-04